Results
1 -
10 of
73Delineation of the interactions between the chemotherapeutic agent eribulin mesylate (E7389) and human CYP3A4, Cancer Chemotherapy and Pharmacology Eribulin: Neue Therapieoption f??r intensiv vorbehandelte Patientinnen, best practice onkologie Rechtzeitiger Therapiebeginn ist entscheidend, best practice onkologie Therapie Erlotinibinduzierter Hautreaktionen: Dermatologische Referenzzentren online, best practice onkologie Story of Eribulin Mesylate: Development of the Longest Drug Synthesis, Synthesis of Heterocycles in Contemporary Medicinal Chemistry Marine Sponge Derived Eribulin in Preclinical and Clinical Studies for Cancer, Handbook of Anticancer Drugs from Marine Origin Inhibitor der Mikrotubuli-Dynamik mit neuartiger Wirkweise, Info Onkologie Eribulin-Monotherapie verl??ngert das Gesamt??berleben, best practice onkologie 46th Annual Meeting of the American Society of Clinical Oncology (ASCO), best practice onkologie Pharmacokinetics of eribulin mesylate in cancer patients with normal and impaired renal function, Cancer Chemotherapy and Pharmacology